Sign inGet started

SPTX

Seaport Therapeutics, Inc.CIK 2042347 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
14

AI insights for SPTX PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for SPTX
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
HOMBACH ROBERT J.Director2$235.8K$02026-06-22
Chen Michael CunyuanChief Scientific Officer3$0$02026-05-04
Gladstein LanaGeneral Counsel3$0$02026-05-04
ARCH Venture Partners XII, L.P.10% Owner5$19.80M$02026-05-04
White LaurenChief Financial Officer3$0$02026-05-04
Torres DeniceDirector3$0$02026-05-04
Loebel AntonyChief Medical Officer3$0$02026-05-04
PureTech Health plc10% Owner6$0$02026-05-04
HEALY JAMESDirector4$0$02026-05-04
PAUL STEVEN MDirector4$0$02026-05-04
Wheadon David E.Director1$0$02026-04-30
Zohar DaphneChief Executive Officer2$0$02026-04-30
Mates SharonDirector1$0$02026-04-30
PETERSON SANDRA EDirector1$0$02026-04-30

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
HOMBACH ROBERT J.Director P Buy2026-06-222026-06-2413,000$18.14 $235.8K13,000SEC↗
Loebel AntonyChief Medical Officer C Conversion deriv2026-05-042026-05-0463,157— $00SEC↗
ARCH Venture Partners XII, L.P10% Owner C Conversion deriv2026-05-042026-05-042,513,686— $00SEC↗
ARCH Venture Partners XII, L.P10% Owner C Conversion deriv2026-05-042026-05-042,681,265— $00SEC↗
PAUL STEVEN MDirector C Conversion deriv2026-05-042026-05-04210,526— $00SEC↗
Torres DeniceDirector C Conversion deriv2026-05-042026-05-0442,105— $00SEC↗
Chen Michael CunyuanChief Scientific Officer C Conversion deriv2026-05-042026-05-0410,526— $00SEC↗
Gladstein LanaGeneral Counsel C Conversion deriv2026-05-042026-05-04105,263— $00SEC↗
White LaurenChief Financial Officer C Conversion deriv2026-05-042026-05-0421,052— $00SEC↗
HEALY JAMESDirector C Conversion deriv2026-05-042026-05-046,052,631— $00SEC↗
HEALY JAMESDirector C Conversion deriv2026-05-042026-05-042,526,315— $00SEC↗
PureTech Health plc10% Owner C Conversion deriv2026-05-042026-05-0640,000,000— $00SEC↗
PureTech Health plc10% Owner C Conversion deriv2026-05-042026-05-068,421,052— $00SEC↗
PureTech Health plc10% Owner C Conversion deriv2026-05-042026-05-063,031,578— $00SEC↗
Loebel AntonyChief Medical Officer C Conversion2026-05-042026-05-0420,109— $020,109SEC↗
ARCH Venture Partners XII, L.P10% Owner C Conversion2026-05-042026-05-042,513,686— $02,513,686SEC↗
ARCH Venture Partners XII, L.P10% Owner C Conversion2026-05-042026-05-042,681,265— $05,194,951SEC↗
ARCH Venture Partners XII, L.P10% Owner P Buy2026-05-042026-05-041,100,000$18.00 $19.80M6,294,951SEC↗
PAUL STEVEN MDirector C Conversion2026-05-042026-05-0467,031— $0863,031SEC↗
Torres DeniceDirector C Conversion2026-05-042026-05-0413,406— $013,406SEC↗
Chen Michael CunyuanChief Scientific Officer C Conversion2026-05-042026-05-043,351— $03,351SEC↗
Gladstein LanaGeneral Counsel C Conversion2026-05-042026-05-0433,515— $033,515SEC↗
White LaurenChief Financial Officer C Conversion2026-05-042026-05-046,702— $06,702SEC↗
HEALY JAMESDirector C Conversion2026-05-042026-05-041,927,159— $01,927,159SEC↗
HEALY JAMESDirector C Conversion2026-05-042026-05-04804,379— $02,731,538SEC↗
PureTech Health plc10% Owner C Conversion2026-05-042026-05-0612,736,014— $013,038,493SEC↗
PureTech Health plc10% Owner C Conversion2026-05-042026-05-06965,255— $016,685,013SEC↗
PureTech Health plc10% Owner C Conversion2026-05-042026-05-062,681,265— $015,719,758SEC↗
Mates SharonDirector A Award deriv2026-04-302026-05-0449,033— $049,033SEC↗
Loebel AntonyChief Medical Officer A Award deriv2026-04-302026-05-0463,680— $063,680SEC↗
HOMBACH ROBERT J.Director A Award deriv2026-04-302026-05-0412,258— $012,258SEC↗
PAUL STEVEN MDirector A Award deriv2026-04-302026-05-04991,192— $0991,192SEC↗
PAUL STEVEN MDirector A Award deriv2026-04-302026-05-0412,258— $012,258SEC↗
Torres DeniceDirector A Award deriv2026-04-302026-05-0412,258— $012,258SEC↗
Chen Michael CunyuanChief Scientific Officer A Award deriv2026-04-302026-05-0463,680— $063,680SEC↗
Gladstein LanaGeneral Counsel A Award deriv2026-04-302026-05-0463,680— $063,680SEC↗
PETERSON SANDRA EDirector A Award deriv2026-04-302026-05-0412,258— $012,258SEC↗
Wheadon David E.Director A Award deriv2026-04-302026-05-0412,258— $012,258SEC↗
White LaurenChief Financial Officer A Award deriv2026-04-302026-05-0463,680— $063,680SEC↗
Zohar DaphneChief Executive Officer A Award deriv2026-04-302026-05-041,486,786— $01,486,786SEC↗
Zohar DaphneChief Executive Officer A Award deriv2026-04-302026-05-04271,813— $0271,813SEC↗